After a three-year-long debate, the federal Food and Drug Administration (FDA) has approved wider distribution of a “morning-after” contraceptive, angering some religious conservatives and anti-abortion groups. FDA officials announced Aug. 24 that they had approved nonprescription sales of “Plan B,” a drug designed to prevent ovulation and fertilization of a woman’s egg. The decision, however, only allows women 18 years…